[Current clinical results of antiplatelet medication].
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects*; D002545:Brain Ischemia / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D004176:Dipyridamole / Q000627:therapeutic use; D004341:Drug Evaluation; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D010974:Platelet Aggregation / Q000187:drug effects; D010979:Platelet Function Tests; D011183:Postoperative Complications / Q000517:prevention & control; D011817:Rabbits; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013923:Thromboembolism / Q000517:prevention & control*; D013924:Thrombophlebitis / Q000517:prevention & control; D014656:Vascular Surgical Procedures
D000925:Anticoagulants; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone
Resultados clínicos actuales de la medicación antiplaquetaria.